Katase Naoki, Lefeuvre Mathieu, Gunduz Mehmet, Gunduz Esra, Beder Levent Bekir, Grenman Reidar, Fujii Masae, Tamamura Ryo, Tsujigiwa Hidetsugu, Nagatsuka Hitoshi
Department of Oral Pathology and Medicine, Graduate school of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Oncol Lett. 2012 Feb;3(2):273-280. doi: 10.3892/ol.2011.473. Epub 2011 Nov 8.
Head and neck squamous cell carcinoma (HNSCC) is one of the most frequently occurring types of cancer worldwide. We focused on the fact that the aberrant function of Wnt/β-catenin signaling is a frequent event in malignancies. Dickkopf (Dkk)-3 is a major negative regulator of Wnt/β-catenin signaling, which is a known tumor suppressor and is down-regulated in various types of cancer. However, the expression profile of the Dkk-3 protein in HNSCC has not yet been reported. The present study was conducted to investigate Dkk-3 protein expression in 90 cases of HNSCC tissue samples and HNSCC-derived cell lines. In contrast to findings available on other types of cancer, the Western blot analysis revealed that HNSCC cell lines expressed the Dkk-3 protein. In immunohistochemistry, 76 cases (84.4%) out of 90 tissue samples were Dkk-3-positive, whereas only 14 cases (15.6%) were negative. Notably, survival analysis showed that the Dkk-3 (-) group exhibited significantly longer disease-free survival (p=0.038), metastasis-free survival (p=0.013) and longer overall survival (p=0.155). The results showed that the Dkk-3 protein was dominantly expressed and may be involved in carcinogenesis and metastasis in HNSCC. Moreover, the findings suggest that the function of Dkk-3 differs depending on the tissue of origin, and that it may exert an oncogenic function in HNSCC.
头颈部鳞状细胞癌(HNSCC)是全球最常见的癌症类型之一。我们关注到Wnt/β-连环蛋白信号通路的异常功能在恶性肿瘤中是常见事件。Dickkopf(Dkk)-3是Wnt/β-连环蛋白信号通路的主要负调节因子,它是一种已知的肿瘤抑制因子,在各种类型的癌症中表达下调。然而,Dkk-3蛋白在HNSCC中的表达谱尚未见报道。本研究旨在调查90例HNSCC组织样本和HNSCC来源的细胞系中Dkk-3蛋白的表达情况。与其他类型癌症的研究结果不同,蛋白质印迹分析显示HNSCC细胞系表达Dkk-3蛋白。在免疫组织化学中,90例组织样本中有76例(84.4%)Dkk-3呈阳性,而只有14例(15.6%)为阴性。值得注意的是,生存分析表明,Dkk-3(-)组的无病生存期(p=0.038)、无转移生存期(p=0.013)显著延长,总生存期也更长(p=0.155)。结果表明,Dkk-3蛋白在HNSCC中呈优势表达,可能参与其致癌和转移过程。此外,研究结果表明,Dkk-3的功能因组织来源而异,它可能在HNSCC中发挥致癌作用。